Postbiotics as Next Generation Biotherapeutics Targeting the Gut-Immune-Metabolic Axis: An Integrative Review.

Abbas A, Weiskirchen R, Bilal M, Afzal MK, Malik A, Akhtar S, Khan M, Rashid I, Khalid F, Akram S, Saleem A, Okoduwa SIR.

Open source

DOI: 10.3390/ph19081184
Published: 2026-07-28
Container: Pharmaceuticals (Basel)
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ph19081184,
  title = {Postbiotics as Next Generation Biotherapeutics Targeting the Gut-Immune-Metabolic Axis: An Integrative Review.},
  author = {Abbas A and  Weiskirchen R and  Bilal M and  Afzal MK and  Malik A and  Akhtar S and  Khan M and  Rashid I and  Khalid F and  Akram S and  Saleem A and  Okoduwa SIR.},
  year = {2026},
  journal = {Pharmaceuticals (Basel)},
  doi = {10.3390/ph19081184},
  url = {https://doi.org/10.3390/ph19081184}
}

RIS

TY  - JOUR
TI  - Postbiotics as Next Generation Biotherapeutics Targeting the Gut-Immune-Metabolic Axis: An Integrative Review.
AU  - Abbas A
AU  -  Weiskirchen R
AU  -  Bilal M
AU  -  Afzal MK
AU  -  Malik A
AU  -  Akhtar S
AU  -  Khan M
AU  -  Rashid I
AU  -  Khalid F
AU  -  Akram S
AU  -  Saleem A
AU  -  Okoduwa SIR.
PY  - 2026
JO  - Pharmaceuticals (Basel)
DO  - 10.3390/ph19081184
UR  - https://doi.org/10.3390/ph19081184
ER  -

APA

A, A., R, W., M, B., MK, A., A, M., S, A., M, K., I, R., F, K., S, A., A, S., & SIR., O. (2026). Postbiotics as Next Generation Biotherapeutics Targeting the Gut-Immune-Metabolic Axis: An Integrative Review.. Pharmaceuticals (Basel). https://doi.org/10.3390/ph19081184

Source records

europe-pmc · retrieved 2026-09-26T02:07:50.290Z
doaj · retrieved 2026-09-26T02:07:50.303Z